Skip to main content
Opening up new opportunities
  • Home
  • News and Events

News & events

Upcoming events

Please save the dates of our upcoming events listed below. We will share formal invitations in due course.

16 August 2023 - an evening event at Canaccord Genuity Wealth Management's Wood Street offices.

29 November 2023 - our annual shareholder seminar, to take place in the afternoon at Everyman Broadgate. 

Recent updates

Interim results for the six month period ending 31 March 2023 

Watch the video presentation with the fund managers:

Transaction in own shares - 8 August 2023

Total Voting Rights and Capital - 31 July 2023

PDMR Dealing - 28 July 2023

Allotment of shares under DRIS - 28 July 2023

Intention to launch an offer for subscription - 27 July 2023

IMS -Q3 2023 - 26 July 2023

Transaction in own shares - 19 July 2023

DRIS Issue Price - 14 July 2023

Transaction in own shares - 12 July 2023

Transaction in own shares - 6 July 2023

Total Voting Rights and Capital - 31 July 2023

PDMR Dealing - 28 July 2023

Allotment of shares under DRIS - 28 July 2023

Intention to launch an offer for subscription - 27 July 2023

IMS -Q3 2023 - 26 July 2023

Transaction in own shares - 19 July 2023

DRIS Issue Price - 14 July 2023

Transaction in own shares - 12 July 2023

Transaction in own shares - 6 July 2023

Total Voting Rights and Capital - 30 June 2023

Transaction in own shares - 28 June 2023

Transaction in own shares - 21 June 2023

Transaction in own shares - 13 June 2023

Dividend Announcement - 13 June 2023

Unaudited Interim Results - 13 June 2023

Transaction in own shares - 7 June 2023

Total Voting Rights and Capital - 31 May 2023

Interim Management Statement - Q2 2023

Transaction in own shares - 18 May 2023

Closed Period notification - 12 May 2023

Transaction in own shares - 10 May 2023

Transaction in own shares - 28 April 2023

Total Voting Rights and Capital - 28 April 2023

Transaction in own shares - 19 April 2023

Transaction in own shares - 13 April 2023

Allotment of shares - 11 April 2023

Transaction in own shares - 6 April 2023

Total Voting Rights and Capital - 31 March 2023

Transaction in own shares - 29 March 2023

Transaction in own shares - 21 March 2023

Issue of Equity - 20 March 2023

Transaction in own shares - 15 March 2023

Transaction in own shares - 8 March 2023

Interim Management Statement - 7 March 2023

Transaction in own shares - 1 March 2023

Total Voting Rights and Capital - 28 February 2023

Transaction in own shares - 22 February 2023

Transaction in own shares - 15 February 2023

PDMR Dealing - 14 February 2023

Issue of Equity Correction - 10 February 2023

Issue of Equity - 10 February 2023

Issue of Equity - 10 February 2023

Close of offer - 10 February 2023

Transaction in own shares - 8 February 2023

Results of 2023 Annual General Meeting - 2 February 2023

Total Voting Rights and Capital - 31 January 2023

DRIS Issue Price - 30 January 2023

Transaction in own shares - 25 January 2023

Disclosure of New Directorship - 24 January 2023

Issue of Equity - 18 January 2023

Transaction in own shares - 17 January 2023

Publication of a Supplementary Prospectus - 6 January 2023

Total Voting Rights and Capital - 31 December 2022

Transaction in own Shares - 21 December 2022

Record date for Special and Final Dividends - 19 December 2022

Full year results and notice of Annual General Meeting - 19 December 2022

Transaction in own shares - 14 December 2022

Issue of Equity - 7 December 2022

Total Voting Rights and Capital - 30 November 2022

Transaction in own shares - 24 November 2022

Disclosure of New Directorship - 24 November 2022

Closed Period Notification - 23 November 2022

Intention to extend use of Over-Allotment facility - 18 November 2022

Allotment of Shares - 14 November 2022

Transaction in own shares - 3 November 2022

Total Voting Rights and Capital - 31 October 2022

Transaction in own shares - 20 October 2022

Issue of Equity - 19 October 2022

Director/PDMR Shareholding - 18 October 2022

Intention to utilise Over-Allotment Facility and Offer Update - 17 October 2022

Transaction in own Shares - 13 October 2022

Close of Early Bird - 11 October 2022

Results of General Meeting - 7 October 2022

Total Voting Rights and Capital - 30 September

Transaction in own shares - 28 September 2022

Transaction in own shares - 22 September 2022

Transaction in own Shares - 15 September 2022

Circular Posted - 5 September 2022

Publication of Prospectus - 5 September 2022

Related Party Transaction - 2 September 2022

Total Voting Rights and Capital - 31 August 2022

Update on Offer for Subscription

Transaction in own shares - 24 August 2022

Transaction in own shares - 12 August 2022

Total Voting Rights and Capital - 29 July 2022

PDMR Notification - 29 July 2022

Allotment of shares under DRIS - 29 July 2022

Transaction in own shares - 28 July 2022

Transaction in own shares - 20 July 2022

DRIS Issue Price - 15 July 2022

Transaction in own shares - 13 July 2022

Total Voting Rights and Capital - 30 June 2022

Transaction in own shares - 29 June 2022

Transaction in own shares - 22 June 2022

Dividend Announcement - 17 June 2022

Unaudited Interim Results - 17 June 2022

Transaction in own shares - 14 June 2022

Intention to launch an offer for subscription - 9 June 2022

Transaction in own shares - 7 June 2022

Directorate Change - 6 June 2022

Total Voting Rights and Capital - 31 May 2022

Transaction in own shares - 26 May 2022

Closed Period Notification - 16 May 2022

Transaction in own shares - 12 May 2022

Transaction in own shares - 6 May 2022

Total Voting Rights and Capital - 29 April 2022

Transaction in own shares -  27 April 2022

Transaction in own shares - 21 April 2022

Transaction in own shares - 13 April 2022

Transaction in own shares - 7 April 2022

Issue of Equity - 7 April 2022

Transaction in own shares - 31 March 2022

Total voting rights and Capital - 31 March 2022

Transaction in own shares - 23 March 2022

Transaction in own shares - 16 March 2022

Transaction in own shares - 3 March 2022

Total Voting Rights and Capital - 28 February 2022

Transaction in own shares - 16 February 2022

PDMR Notification - 10 February 2022

Allotment of shares under DRIS - 10 February 2022

Transaction in own shares - 9 February 2022

Directorate Change - 3 February 2022

Result of Annual General Meeting - 3 February 2022

Interim Management Statement - Quarter ending 31 December 2021 - 3 February 2022

Total Voting Rights and Capital - 31 January 2022

DRIS Issue Price - 28 January 2022

Transaction in own shares - 27 January 2022

Transaction in own shares - 19 January 2022

Transaction in own shares - 13 January 2022

Transaction in own shares - 12 January 2022

Transaction in own shares - 10 January 2022

Total Voting Rights and Capital - 31 December 2021

Transaction in own shares - 22 December 2021

Transaction in own shares - 17 December 2021

Record date for dividend - 17 December 2021

Full year results and Notice of AGM - 17 December 2021

Related party transaction - 14 December 2021

Transaction in own shares - 9 December 2021

Transaction in own shares - 2 December 2021

Total Voting Rights and Capital - 30 November 2021

Directorate Change - 29 November 2021

Issue of Equity - 25 November 2021

Interim Management Statement - 24 November 2021

Transaction in own shares - 24 November 2021

Closed Period Notification - 18 November 2021

Transaction in own Shares - 17 November 2021

Allotment of Shares - 9 November 2021

PDMR Notification - 5 November 2021

Transaction in own Shares - 4 November 2021

Total Voting Rights and Capital - 29 October 2021

Allotment of Shares under DRIS - 29 October 2021

PDMR Notification - 22 October 2021

Close of Offer to Further Applications - 22 October 2021

Transaction in own Shares - 20 October 2021

Allotment of Shares - 19 October 2021

DRIS Issue Price - 18 October 2021

PDMR Notification - 18 October 2021

Allotment of Shares - 12 October 2021

Results of General Meeting - 6 October 2021

Total Voting Rights and Capital - 30 September 2021

Transaction in own shares - 29 September 2021

Special Dividend Announcement and Update on Shareholder Event

Offer Update - Intention to Utilise Over Allotment Facility

Transaction in Own Shares - 22 September 2021

Offer Update - Closure of early Bird - 21 September 2021

Transaction in own shares - 15 September 2021

Transaction in own shares - 8 September 2021

Transaction in own shares - 3 September 2021

Publication of a Circular 2 September 2021

Publication of a Prospectus 2 September 2021

Total Voting Rights and Capital 31 August 2021

Transaction in own shares - 25 August 2021

Transaction in own shares - 18 August 2021

Transaction in own shares - 12 August 2021

PDMR Dealing - 10 August 2021

Interim Management Statement - 10 August 2021

Transaction in own shares - 4 August 2021

Total Voting Rights and Capital - 30 July 2021

Transaction in own shares - 30 July 2021

Allotment of shares under DRIS - 30 July 2021

Transaction in own shares - 21 July 2021

DRIS Issue price - 19 July 2021

Transaction in own shares - 14 July 2021

Transaction in own shares - 9 July 2021

Total Voting Rights and Capital - 30 June 2021

Transaction in own shares - 23 June 2021

Dividend Announcement - 22 June 2021

Unaudited Interim Results - 22 June 2021

Intention to launch an offer for subscription - 22 June 2021

Transaction in own shares - 16 June 2021

Transaction in own shares - 9 June 2021

Transaction in own shares - 3 June 2021

Share Cancellation - 1 June 2021

Total Voting Rights and Capital - 28 May 2021

Transaction in own shares - 26 May 2021

Closed Period Notification 21 May 2021

Transaction in own shares - 18 May 2021

Transaction in own shares - 12 May 2021

Total Voting Rights and Capital - 7 May 2021

Transaction in own shares - 7 May 2021

Transaction in own shares - 28 April 2021

Transaction in own shares - 23 April 2021

Transaction in own shares - 15 April 2021

Offer Update - 15 April 2021

Issue of Equity - 12 April 2021

Transaction in own shares - 1 April 2021

Total Voting Rights and Capital - 1 April 2021

Transaction in own shares - 23 March 2021

Transaction in own shares - 17 March 2021

Transaction in own shares - 5 March 2021

PDMR Notification - 1 March 2021

Total Voting Rights and Capital - 1 March 2021

Allotment of shares - 1 March 2021

Allotment of shares - 26 February 2021

Interim Management Statement - 25 February 2021

Transaction in own shares - 24 February 2021

Transaction in own shares - 17 February 2021

Offer Update - 15 February 2021

Allotment of Shares under DRIS- update - 12 February 2021

PDMR Notification - 12 February 2021

Transaction in own Shares - 11 February 2021

Allotment of Shares under DRIS - 11 February 2021

Allotment of Shares - 10 February 2021

Director Resignation - 4 February 2021

Results of AGM - 4 February 2021

Total Voting Rights and Capital - 1 February 2021

DRIS issue price - 28 January 2021

Transaction in own shares - 27 January 2021

Allotment of shares - 14 January 2021

Transaction in own shares - 13 January 2021

Company Secretary Change - 12 January 2021

Publication of a Supplementary Prospectus - 8 January 2021

Offer Update 7 January 2021 

Dividend Declaration - Correction 7 January 2021

Total Voting Rights and Capital 4 January 2021

Transaction in own shares 23 December 2020

Dividend Declaration 22 December 2020

Annual Financial Report 22 December 2020

Transaction in own shares 9 December 2020

Allotment of Shares 8 December 2020

Total Voting Rights and Capital 1 December 2020

Transaction in own shares 18 November 2020

Closed Period Notification 17 November 2020

Transaction in own shares 10 November 2020

Director Declaration 9 November 2020

Allotment of Shares 6 November 2020

Transaction in own shares 3 November 2020

Total Voting Rights and Capital 2 November 2020

Directorate Change 30 October 2020

Transaction in own shares 13 October 2020

Allotment of shares 9 October 2020

Total Voting Rights and Capital 1 October 2020

Transaction in own shares 30 September 2020

General Meeting 29 September 2020

Transaction in own shares 10 September 2020

Transaction in own shares 4 September 2020

Publication of a Prospectus 2 September 2020

Total Voting Rights and Capital 1 September 2020

Transaction in own shares 25 August 2020

Interim Management Statement 14 August 2020

Total Voting Rights and Capital 3 August 2020

Transaction in own shares 29 July 2020

Transaction in own shares 17 July 2020

Transaction in own shares 10 July 2020

Total Voting Rights and Capital 1 July 2020

Transaction in own shares 25 June 2020

Dividend Declaration 23 June 2020

Half-year report 23 June 2020

Intention to launch an offer for subscription 22 June 2020

Transaction in own shares 10 June 2020

Total Voting Rights and Capital 1 June 2020

Closed Period Notification 18 May 2020

Transaction in own shares 15 May 2020

Interim Management Statement 12 May 2020

Total Voting Rights and Capital 1 May 2020

Transaction in own shares 22 April 2020

Transaction in own shares 17 April 2020

Total voting rights and capital 1 April 2020

Transaction in own shares 5 March 2020

Total voting rights and capital 3 March 2020

Transaction in own shares 20 February 2020

Transaction in own shares 13 February 2020

Transaction in own shares 6 February 2020

Result of AGM 4 February 2020

Total voting rights and capital 3 February 2020

Transactions in own shares 24 January 2020

Transaction in own shares 17 January 2020

Transaction in own shares 10 January 2020

Dividend Declaration 19 December 2019

Annual Financial Report 19 December 2019

Final Results 19 December 2019

Transaction in own shares 12 December 2019

Transaction in own shares 29 November 2019

Director Declaration: Additional Directorship 26 November 2019

Transaction in own shares 22 November 2019

Transaction in own shares 8 November 2019

Closed Period Notification 8 November 2019

Directorate Change 4 November 2019

Transaction in own shares 31 October 2019

Transaction in own shares 25 October 2019

Transaction in own shares 17 October 2019

Transaction in own shares 30 September 2019

Transaction in own shares 20 September 2019

Transaction in own shares 11 September 2019

Transaction in own shares 30 August 2019

Transaction in own shares 30 July 2019

Transaction in own shares 5 July 2019

Transaction in own shares 28 June 2019

Dividend declaration 27 June 2019

Half-year report 27 June 2019

Half-yearly report and closed period update 21 June 2019

Transaction in own shares 14 June 2019

Transaction in own shares 7 June 2019

Transaction in own shares 24 May 2019

Transaction in own shares 15 May 2019

Closed Period Notification

Offer Update 11 April 2019

Issue of Equity 11 April 2019

Transaction in Own Shares 10 April 2019

Disclosure of Related Party Transaction 10 April 2019

Transaction in Own Shares 1 March 2019

Transaction in Own Shares 15 February 2019

Transaction in Own Shares 8 February 2019

Issue of Equity 5 February 2019

Result of AGM 5 February 2019

Transaction in Own Shares 31 January 2019

Offer for Subscription - Supplementary Prospectus - 25 January 2019

Offer Update 24 January 2019

Transaction in Own Shares 17 January 2019

Dividend Declaration 8 January 2019

Annual Financial Report 8 January 2019

Final Results 8 January 2019

Transaction in Own Shares 4 January 2019

Issue of Equity 4 January 2019

Issue of Equity 13 December 2018

Transaction in Own Shares 30 November 2018

Offer Update 28 November 2018

Transaction in Own Shares 16 November 2018

Issue of Equity 15 November 2018

Transaction in Own Shares 26 October 2018

PDMR 25 October 2018

Issue of Equity 25 October 2018

General Meeting 19 October 2018

Transaction in Own Shares 28 September 2018

Reduction of Share Capital 26 September 2018

Publication of Circular and Notice of General Meeting 24 September 2018

Dividend Declaration 19 September 2018

Publication of Prospectus 19 September 2018

Change of Name 7 September 2018

Offer Update 28 August 2018

Transaction in Own Shares 20 July 2018

Offer Update 17 July 2018

Transaction in Own Shares 13 July 2018

Issue of Equity 4 July 2018

Transaction in Own Shares 29 June 2018

Offer Update 29 June 2018

Dividend Declaration 26 June 2018

Half-yearly report 26 June 2018

Director Declaration: Additional Directorship 18 June 2018

Transaction in Own Shares 15 June 2018

Issue of Equity 12 June 2018

Issue of Equity 7 June 2018

Transaction in Own Shares 18 May 2018

Related Party Transaction 16 May 2018

Directorate Change 14 May 2018

Offer Update: Use of Over Allotment 8 May 2018

Transaction in Own Shares 4 May 2018

Issue of Equity 3 May 2018

Transaction in Own Shares 27 April 2018

Transaction in Own Shares 20 April 2018

Transaction in Own Shares 6 April 2018

Issue of Equity 6 April 2018

Issue of Equity 5 April 2018

Issue of Equity 29 March 2018

Issue of Equity 27 March 2018

Merger Update: Approval of Scheme 23 March 2018

Director PDMR Shareholding 20 March 2018

Issue of Equity 20 March 2018

Results of Meeting 16 March 2018

Director Declaration: Additional Directorship 27 February 2018

Transaction in Own Shares 23 February 2018

Publication of Prospectus 12 February 2018

Offer Update re Possible Merger 6 February 2018

Transaction in Own Shares 2 February 2018

Results of AGM 25 January 2018

Transaction in Own Shares 19 January 2018

Transaction in Own Shares 12 January 2018

Transaction in Own Shares 5 January 2018

Transaction in Own Shares 29 December 2017

Doc re Possible Merger 27 December 2017

Dividend Declaration 19 December 2017

Final Results 19 December 2017

Transaction in Own Shares 15 December 2017

Transaction in Own Shares 10 November 2017

Transaction in Own Shares 3 November 2017

Transaction in Own Shares 27 October 2017

Transaction in Own Shares 13 October 2017

Publication of Supplementary Prospectus 2 October 2017

Transaction in Own Shares 11 August 2017

Interim Management Statement 7 August 2017

Transaction in Own Shares 4 August 2017

Transaction in Own Shares 28 July 2017

Transaction in Own Shares 14 July 2017

Transaction in Own Shares 30 June 2017

Transaction in Own Shares 16 June 2017

Transaction in Own Shares 2 June 2017

Transaction in Own Shares 25 May 2017

Dividend Declaration 24 May 2017

Half Yearly Report 24 May 2017

Transaction in Own Shares 5 May 2017

Transaction in Own Shares 21 April 2017

Transaction in Own Shares 12 April 2017

Issue of Equity 6 April 2017

Transaction in Own Shares 31 March 2017

Interim Management Statement 1 October 2016 to 31 December 2016

Transaction in Own Shares 24 March 2017

Issue of Equity 20 March 2017

Offer Update - Closure of VCT 1 15 March 2017

Transaction in Own Shares 10 March 2017

Offer Update - Use of Over Allotment 9 March 2017

Issue of Equity 27 February 2017

Transaction in Own Shares 17 February 2017

Director PDMR Shareholding 14 February 2017 

Issue of Equity 14 February 2017

Transaction in Own Shares 10 February 2017

Issue of Equity 2 February 2017

Transaction in Own Shares 27 January 2017

Transaction in Own Shares 13 January 2017

Result of Meeting 12 January 2017

Result of AGM 12 January 2017

Director PDMR Shareholding 12 January 2017

Issue of Equity 12 January 2017

Issue of Equity 5 January 2017 

Circ re Offers for Subscription 15 December 2016 

Publication of Propsectus 14 December 2016 

Dividend Declaration 7 December 2016

Annual Financial Report 7 December 2016

Final Results 7 December 2016 

Issue of Equity 17 November 2016 

Offer Update - Intention to Launch 16 November 2016  

Issue of Equity 19 October 2016

Issue of Equity 30 September 2016 

Transaction in Own Shares 23 September 2016 

Transaction in Own Shares 9 September 2016 

Interim Management Statement 1 April 2016 to 30 June 2016

Issue of Equity 31 August 2016 

Issue of Equity 5 August 2016

Transaction in Own Shares 29 July 2016

Issue of Equity 23 June 2016

Publication of Supplementary Prospectus 17 June 2016 

NAV Release

Press Release

Shareholder Events

Please see upcoming events at the top of this page.

Disclaimer

The materials contained herein have been prepared for use solely by individuals who are resident in the United Kingdom for tax and investment purposes. The materials contained herein are not for release, publication, or distribution, directly or indirectly, in whole or in part, to US persons or into or within the United States (including its territories and possessions, any state of the United States and the District of Columbia), Australia, Canada, Japan, the Republic of South Africa or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

There will be no public offering of the securities referred to herein and on the pages that follow in the United States, Australia, Canada, Japan, the Republic of South Africa or any other restricted jurisdiction. The securities referred to herein and on the pages that follow may not be offered, sold, resold, pledged, delivered, distributed or otherwise transferred, directly or indirectly, into or within the United States, Australia, Canada, Japan or the Republic of South Africa or to any national, resident or citizen of the United States, Australia, Canada, Japan or the Republic of South Africa. Potential users of this information are requested to inform themselves about and to observe any such restrictions.

The information on the pages that follow may contain forward‑looking statements. Any statement other than a statement of historical fact is a forward‑looking statement.  Actual results may differ materially from those expressed or implied by any forward‑looking statement. The Company does not undertake any obligation to update or revise any forward‑looking statements, whether as a result of new information, future events, or otherwise. You should not place undue reliance on any forward‑looking statement, which speaks only as of the date of its issuance.

By using this website you confirm that you have read, understood, and accepted these conditions, including (without limitation) the risks noted below which may be involved in investing in the shares of the Company. The Company may change these conditions. The changes will be posted on the website and you should check regularly to see any changes or updates to these conditions. Your access to this website is governed by the version of these conditions then in force.

1. Terms and conditions

The terms and conditions set out below apply to your use of the Company’s website. Please read them.

The "Company" or the "VCT" means Hargreave Hale AIM VCT plc and references to "the Company’s website" are to the website available at www.hargreaveaimvcts.co.uk and also include, but are not limited to, the text, documents, images, links, sounds, graphics, and video sequences displayed on the website (the "Materials").

The Company’s website is operated by Canaccord Genuity Wealth Limited (“CGWL”). CGWL is a private limited company incorporated in England and Wales with company number 03739694 and has its registered office at 88 Wood Street, London, England EC2V 7QR. CGWL is authorised and regulated by the Financial Conduct Authority with firm reference number 194927. Details of CGWL’s registration can be found on the FCA’s website at https://register.fca.org.uk/s/.

By clicking and entering www.hargreaveaimvcts.co.uk you agree that you have read and accept these terms and conditions. If you do not agree, do not use www.hargreaveaimvcts.co.uk. 

2. Intended audience and access to the Company's website

No information contained on the Company's website or in the Materials should be taken as a recommendation, offer or invitation to buy, sell, hold or otherwise deal with the shares or other financial instruments of any entity nor is it intended to solicit any such offer or invitation. Nothing on the Company’s website or in the Materials constitutes or is intended to constitute investment or other advice (including, without limitation, legal or tax advice) or investment research and you should not act upon any information contained on the Company’s website or in the Materials without first consulting a financial or other professional adviser.

The information in the Company’s website is only for the attention of individuals who are resident in the United Kingdom for tax and investment purposes. It is your responsibility to be aware of and to observe all applicable law and regulation in the United Kingdom. To the extent that you are not resident in the United Kingdom for tax and investment purposes, do not use this website.

The Company’s website is not intended to offer or to promote the offer or sale of the shares in the Company (the "Shares") in the United States or to US Persons. Each acquirer of the Shares will be deemed to represent, amongst other things, that (i) it is not in the United States, (ii) it is not a US Person or acquiring the Shares for the account or benefit of a US Person, and (iii) it is acquiring the Shares in an "offshore transaction" meeting the requirements of Regulation S under the Securities Act.

The content of the Company’s website constitutes a ‘financial promotion’ for the purposes of the UK regulatory regime. The content of the Company’s website has therefore been issued and approved for the purposes of section 21 of the Financial Services and Markets Act 2000 by CGWL which is authorised and regulated by the Financial Conduct Authority (with firm reference number 194927). Nonetheless, the content of this website does not constitute investment or other advice given by CGWL and you should not act upon any such content or the Materials without first consulting a financial or other professional adviser.

3. Risks of investing in VCTs

Investing in a VCT (including the Company) carries a high level of risk and it should be remembered that the price of shares in a VCT, and the income from such shares (if any), may go down as well as up. An investment in the VCT is only suitable for investors who are capable of evaluating the risks and merits of such investment and who understand the potential risk of capital loss (which may be equal to the whole amount invested). Further detail on the risks involved in investing in VCTs is set out in the “Risks of investing in VCTs” section on the front page of this website.

The latest annual report, factsheet and prospectus can be found in the document library. These documents include a more comprehensive list of the risks associated with this product. Please ensure that you have read and considered carefully each of the risks identified in these documents before investing in the VCT.

4. Privacy policy

The Company respects the privacy of individuals who visit the Company’s website and is careful to ensure that information disclosed to the Company in confidence is treated confidentially. The Company has a privacy policy in place which governs your use of the website and, by using the website, you confirm that you have read, understood and accept the Company’s privacy policy. A full copy of the Company's full privacy policy can be found here.

5. Limitation of liability

Use of the Company’s website and the Materials are at your sole risk. The Company and CGWL will not be liable to any person for any direct, indirect, special or consequential, losses, damages, or awards of any kind, howsoever caused, as a result of the use of or inability to use, or reliance on, the Company’s website or any of the Materials. To the maximum extent permitted by applicable law and regulation, the Company and CGWL exclude all warranties, conditions, terms, undertakings, and representations (excepting fraudulent misrepresentation) of any kind, express or implied, statutory or otherwise in connection with the Company’s website and the Materials. Nothing in these terms and conditions shall be taken to limit or exclude any liability which may not otherwise be limited or excluded under applicable law or regulation.

Nothing in this website should be construed as investment, tax, legal, or other advice, nor is it to be relied upon in making an investment decision. Those accessing the website should consult their financial advisers regarding the suitability of any of the products referred to on this website.  The value of investments and the income from them may go down as well as up and an investor may receive back less than the original investment. Past performance is not necessarily a guide to future performance.

Trading in securities in smaller companies or a VCT (such as the Company) which invest in emerging markets may involve greater risks and be subject to more abrupt price movements than trading in securities of larger companies.

6. Disclaimer

The Materials and the Company’s website are provided on an "as is" and "as available" basis and do not purport to be full or complete.  The Company and CGWL give no warranties (express, implied, or statutory) as to satisfactory quality or fitness for purpose of the Materials, including, without limitation, as to the accuracy, validity, timeliness, merchantability, or completeness of any information or data contained therein (whether prepared by the Company or by any third party), or that any of the Materials or that the Company’s website will be provided uninterrupted or free from errors or that any identified defect will be corrected.  The Company and CGWL have the right to suspend or withdraw the provision of all or any of the Company’s website or the Materials without prior notice at any time. You are entirely responsible for your use of the website and for the consequences of relying on any content.  Further, no warranty of any kind is given that the Company’s website and the Materials are free from any virus or other malicious, destructive, or corrupting code, program, or macro.  The Company and CGWL do not warrant that the Company’s website or the server(s) that make(s) them available are free of any virus or other harmful elements.

To the maximum extent permitted by applicable law and regulation, the Company and CGWL disclaim all liability to you arising out of your use of the website. In particular, the Company and CGWL shall not be liable for any direct or indirect loss or damage to you, any loss of profits, loss of business, revenue, data, goodwill, or anticipated or consequential loss or damage.

Reference in the Company’s website and/or the Materials to any hypertext link, product, process, or service does not imply the Company’s and/or CGWL’s support for, or endorsement or recommendation of the provider thereof or the product, process, or service to which reference is made.  The Company’s website may contain hypertext links to other websites, resources, or other third parties.  The Company and CGWL are not responsible for the availability of, and accepts no liability in relation to, these external websites or their contents. Each of the Company and CGWL is not a sponsor, partner, promoter, or publisher of any such website.

7. Severance

If any provision of these terms and conditions is found to be illegal, invalid or unenforceable, the invalidity of that provision shall not affect the validity of the remaining provisions of these terms and conditions which shall remain in full force and effect.

8. Governing law

The agreement between you and the Company relating to your use and browsing of the Company’s website is governed by and shall be construed in accordance with the laws of England and Wales and you agree that the Courts of England shall have exclusive jurisdiction over any disputes arising in relation to such use and browsing.  These terms and conditions may not be modified unless the Company agrees in writing.

9. Use of cookies

This website will use a cookie to confirm that this disclaimer has been acknowledged. The cookie lasts only as long as your browser is open and cannot be used to obtain any private data about you. You do not have to accept cookies from this site but, if you do not, you will be required to acknowledge these terms and conditions on every page. Please refer to the Company's cookies policy www.hargreaveaimvcts.co.uk for further information on how cookies are used.

10. The Materials that you are seeking to access are not directed at and may not be viewed by or distributed to persons who are resident outside the United Kingdom, including but not limited to:

  • who are in the United States or who are, or are acting for the account or benefit of, US Persons; or
  • who are in a jurisdiction where it is not lawful to access the Materials.


By clicking "I accept" below, you represent, warrant and agree that you (1) have read and understood the terms and conditions and other information set out above, (2) agree to be bound by its terms and acknowledge that the Company and its affiliates, subsidiaries, directors and advisers may rely on your agreement, (3) are permitted under applicable laws and regulations to receive the information contained in the pages that follow and, (4) agree that you will not transmit or otherwise send any information contained in this website to any person in the United States, to any US Person, or to publications with a general circulation in the United States.  If you cannot so certify and agree, you must click the button labelled "I decline" or otherwise exit this website.